Bio Lum Sciences

Answer: BioLum Sciences's official website is https://biolumsciences.com

Answer: BioLum Sciences's revenue is Under $1 Million

Answer: BioLum Sciences's SIC: 7371

Answer: BioLum Sciences has 1-10 employees

Answer: BioLum Sciences is in Biotechnology

Answer: BioLum Sciences contact info: Phone number: Website: https://biolumsciences.com

Answer: Leveraging biomarker analysis with an integrated approach, BioLum aims to transform precision medicine and early disease detection. Were committed to delivering value from early therapeutic discovery through late stage development, and ultimately into clinical application. Our preclinical services and assays provide the insights needed for more efficient and cost-effective therapeutic R&D. We work with leading pharmaceutical companies and researchers to advance much-needed therapies. By better understanding signaling pathways, mechanisms of action, and cellular interactions in complex complex diseases, we can enhance therapeutic efficacy and enable precision medicine. Tailored to evolving needs and industry trends, our services span the preclinical cycle to streamline development: -biomarker analysis -compound library screening -efficacy testing -rapid evaluation methods -custom assay development -small molecule synthesis -drug repurposing -quantitative and qualitative insights -early target identification and validation -ADME -dose dependency testing -in vitro analysis -PK/PD -formula optimization -probe synthesis and development With a focus on reactive oxygen, nitrogen, and sulfur species (RONSS), BioLum's core assay kits (NO, ONOO-, H2O2) outperform gold standards (including Griess & DAF), with compatibility in a variety of traditionally challenging specimens including plasma, blood, serum, EBC, and living cells. Our advanced chemiluminescence improves signal-to-noise by mitigating background autofluorescence, ensuring superior accuracy and precision. BioLum's novel assays are designed for HTS with clinical viability and ease of use in mind for clinical translation, to empower both therapeutic developers and clinicians. Disease areas include: CVD (HF, CAD, PAH), inflammatory disorders, TME studies, neurological diseases, pain management, respiratory conditions (asthma, COPD), and immunological disorders.

Answer:

• Facebook
• Twitter
• LinkedIn